Literature DB >> 7791396

Symposium on geriatrics--Part I: Drug prescribing for elderly patients.

D S Chutka1, J M Evans, K C Fleming, K G Mikkelson.   

Abstract

OBJECTIVE: To describe the pharmacokinetic and pharmacodynamic changes that occur with aging and to discuss common problems noted with the use of medications often prescribed for elderly patients.
DESIGN: We searched the medical literature, reviewed pertinent articles, and summarized drug-related information applicable to geriatric patients.
RESULTS: Use of medications is common in the elderly population; most elderly persons take two or more different medications each day. Aging is associated with anatomic and physiologic changes that can have an effect on how medications are handled. Such changes include alterations in various volumes of drug distribution and in drug absorption, metabolism, and clearance. Elderly patients may also have increased or decreased drug effects because of alteration in receptor response. These changes in pharmacokinetics and pharmacodynamics may result in a prolonged drug half-life, an increased potential for drug toxicity, and a greater likelihood for adverse drug reactions.
CONCLUSION: Medications for elderly patients should be prescribed only after the anatomic and physiologic changes of aging are understood and with increased surveillance for potential drug toxicity or adverse drug reactions.

Entities:  

Mesh:

Year:  1995        PMID: 7791396     DOI: 10.4065/70.7.685

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  17 in total

Review 1.  Pharmacokinetic drug interaction profiles of proton pump inhibitors.

Authors:  Henning Blume; Frank Donath; André Warnke; Barbara S Schug
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

Review 3.  Bone and joint infections in the elderly: practical treatment guidelines.

Authors:  J T Mader; M E Shirtliff; S Bergquist; J H Calhoun
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

4.  Adverse drug events in U.S. adult ambulatory medical care.

Authors:  Urmimala Sarkar; Andrea López; Judith H Maselli; Ralph Gonzales
Journal:  Health Serv Res       Date:  2011-05-10       Impact factor: 3.402

Review 5.  Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly.

Authors:  Ayman M Noreddin; Virginia Haynes
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

6.  Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects.

Authors:  C Trivalle; T Cartier; C Verny; A-M Mathieu; P Davrinche; H Agostini; L Becquemont; P Demolis
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

7.  Impact of Pharmacist-Provided Medication Therapy Management on Healthcare Quality and Utilization in Recently Discharged Elderly Patients.

Authors:  Jordan D Haag; Amanda Z Davis; Robert W Hoel; Jeffrey J Armon; Laura J Odell; Ross A Dierkhising; Paul Y Takahashi
Journal:  Am Health Drug Benefits       Date:  2016-07

8.  Single-dose pharmacokinetics of rifapentine in elderly men.

Authors:  A C Keung; M G Eller; S J Weir
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

Review 9.  Drug treatment of skin and soft tissue infections in elderly long-term care residents.

Authors:  B H Lertzman; A A Gaspari
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

Review 10.  Acute septic arthritis.

Authors:  Mark E Shirtliff; Jon T Mader
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.